- WB
Supplier Data
Western blot - Anti-TARC/CCL17 antibody [EPR28961-9] (AB323800)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of TARC/CCL17 is upregulated in response to LPS and IL-4 treatment (PMID : 18004070).
The identity of the bands higher than 37 kDa are unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-TARC/CCL17 antibody [EPR28961-9] (ab323800) at 1/1000 dilution
Lane 1:
Untreated RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 30 µg
Lane 2:
RAW 264.7 treated with 100ng/ml LPS for 24 hours, 10ng/ml IL-4 for 20 hours and 300ng/ml BFA for 4 hours whole cell lysate at 30 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 11 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-TARC/CCL17 antibody [EPR28961-9] (AB323800)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of TARC/CCL17 is upregulated in response to M-CSF, GM-CSF and BFA treatment (PMID : 27525438).
In Western blot, Anti-Integrin alpha V antibody [EPR16800] staining at 1/5000 dilution.
All lanes:
Western blot - Anti-TARC/CCL17 antibody [EPR28961-9] (ab323800) at 1/1000 dilution
Lane 1:
Untreated Mouse bone marrow lysate at 20 µg
Lane 2:
Mouse bone marrow treated with 100ng/mL M-CSF for 7 days, 20ng/ml GM-CSF and 300ng/ml BFA for 16 hours lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 11 kDa,125 kDa
false
Exposure time: 180s
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com